Pricing Log in Create free account

Edgewise Therapeutics, Inc. (EWTX) vs Xenon Pharmaceuticals Inc. (XENE)

Edgewise Therapeutics, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Edgewise Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.7B — 1.2× the size. Across the 10 metrics below, Edgewise Therapeutics, Inc. leads on 6 and Xenon Pharmaceuticals Inc. on 4.

Valuation

Metric EWTX XENE Biotechnology median
P/E n/m n/m 10.26
P/S n/m 222.58 9.18
P/B 9.39 3.03 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 169.19 8.98
Earnings yield (4.73%) (12.53%) (34.89%)
Free cash flow yield (3.77%) (8.98%) (24.52%)

Profitability

Metric EWTX XENE Biotechnology median
Gross margin 0.00% 28.40% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.03%) (43.62%) (50.12%)
Return on assets (36.09%) (41.54%) (45.60%)
Return on invested capital 0.00% (88.54%) 0.00%

Growth

Metric EWTX XENE Biotechnology median
Revenue growth (TTM) — (8.15%) 6.26%
EPS growth (last fiscal year) (12.41%) (44.85%) 29.88%
Revenue growth, 5-year CAGR — 89.00% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EWTX XENE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.24 21.02 4.89
Net debt to EBITDA 2.69 1.48 1.01

Dividend

Metric EWTX XENE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EWTX XENE Biotechnology median
Market cap 4.22b 3.65b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack